We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ES icon
201
Eversource Energy
ES
$26.9B
$7.33M 0.08%
87,991
+4,538
+5% +$376K
RMD icon
202
ResMed
RMD
$32.8B
$7.26M 0.08%
37,836
+773
+2% +$126K
SYY icon
203
Sysco
SYY
$40.5B
$7.26M 0.08%
132,760
+1,243
+0.9% +$65.4K
WEC icon
204
WEC Energy
WEC
$35.6B
$7.23M 0.08%
82,497
+1,189
+1% +$107K
VRSK icon
205
Verisk Analytics
VRSK
$23.5B
$7.22M 0.08%
42,436
+196
+0.5% +$31K
FICO icon
206
Fair Isaac
FICO
$22.6B
$7.2M 0.08%
17,224
+599
+4% +$219K
CLX icon
207
Clorox
CLX
$12.8B
$7.18M 0.08%
32,719
+369
+1% +$73.7K
A icon
208
Agilent Technologies
A
$41.9B
$7.14M 0.08%
80,755
+986
+1% +$80.8K
OKE icon
209
Oneok
OKE
$58.3B
$7.12M 0.08%
214,387
-38,692
-15% -$1.26M
CTLT
210
DELISTED
CATALENT, INC.
CTLT
$7.08M 0.08%
96,589
+7,758
+9% +$527K
CMG icon
211
Chipotle Mexican Grill
CMG
$41.3B
$7.06M 0.08%
335,600
+6,000
+2% +$111K
TEL icon
212
TE Connectivity
TEL
$62B
$7.04M 0.08%
86,267
+52
+0.1% +$3.92K
CDNS icon
213
Cadence Design Systems
CDNS
$89B
$7.01M 0.08%
73,017
+691
+1% +$57.8K
AIG icon
214
American International
AIG
$39.8B
$6.96M 0.08%
223,369
-872
-0.4% -$24.5K
KR icon
215
Kroger
KR
$34.3B
$6.96M 0.08%
205,616
-1,109
-0.5% -$36K
YUM icon
216
Yum! Brands
YUM
$41B
$6.84M 0.08%
78,718
+755
+1% +$64.5K
AZO icon
217
AutoZone
AZO
$49.7B
$6.83M 0.08%
6,056
-86
-1% -$90.6K
MNST icon
218
Monster Beverage
MNST
$90.1B
$6.78M 0.08%
391,096
-2,512
-0.6% -$41K
PCAR icon
219
PACCAR
PCAR
$69B
$6.77M 0.08%
135,629
+1,899
+1% +$88.8K
MCHP icon
220
Microchip Technology
MCHP
$43.1B
$6.76M 0.08%
128,326
+5,128
+4% +$231K
MASI
221
DELISTED
Masimo
MASI
$6.74M 0.08%
29,566
+1,405
+5% +$308K
AFL icon
222
Aflac
AFL
$60.5B
$6.7M 0.08%
186,080
-3,122
-2% -$113K
CMI icon
223
Cummins
CMI
$87.8B
$6.69M 0.08%
38,584
-906
-2% -$145K
HCA icon
224
HCA Healthcare
HCA
$89.8B
$6.68M 0.08%
68,873
+680
+1% +$70.7K
SLB icon
225
SLB Ltd
SLB
$78.1B
$6.67M 0.08%
362,964
+6,120
+2% +$107K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.